We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

134 hedge funds and large institutions have $1.01B invested in Genomic Health, Inc. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

100% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 29

8% more funds holding

Funds holding: 124 → 134 (+10)

0% more capital invested

Capital invested by funds: $1.01B → $1.01B (+$809K)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
134
Holders Change
+10
Holders Change %
+8.06%
% of All Funds
3.34%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
58
Reduced
29
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$13.3M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$2.67M
3
NI
Numeric Investors
Massachusetts
+$2.62M
4
Morgan Stanley
Morgan Stanley
New York
+$2.57M
5
Goldman Sachs
Goldman Sachs
New York
+$2.49M

Top Sellers

Rank Fund Capital Flow
1
CWAM
Columbia Wanger Asset Management
Illinois
-$8.86M
2
BlackRock
BlackRock
New York
-$7.91M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$4.6M
4
SCA
Secor Capital Advisors
New York
-$1.51M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
51
Bogle Investment Management
Massachusetts
$1.42M -$509K -16,136 -27%
Two Sigma Investments
52
Two Sigma Investments
New York
$1.35M -$1.24M -39,228 -48%
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$1.25M -$130K -4,114 -10%
Macquarie Group
54
Macquarie Group
Australia
$1.22M – – –
CIP
55
Convergence Investment Partners
Florida
$1.14M +$29.3K +928 +3%
TA
56
Teachers Advisors
New York
$1.13M – – –
First Trust Advisors
57
First Trust Advisors
Illinois
$1.13M +$34.5K +1,094 +3%
Swiss National Bank
58
Swiss National Bank
Switzerland
$1.09M – – –
CS
59
Credit Suisse
Switzerland
$1.02M +$378K +11,993 +61%
Deutsche Bank
60
Deutsche Bank
Germany
$1.01M -$516K -16,355 -34%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$1.01M -$114K -3,611 -10%
Los Angeles Capital Management
62
Los Angeles Capital Management
California
$841K +$612K +19,390 +285%
FNBOO
63
First National Bank of Omaha
Nebraska
$824K +$11K +350 +1%
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$800K +$8.52K +270 +1%
SO
65
STRS Ohio
Ohio
$779K +$56.8K +1,800 +8%
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$735K +$63.1K +2,000 +10%
Russell Investments Group
67
Russell Investments Group
United Kingdom
$727K +$199K +6,304 +39%
KB
68
Kimelman & Baird
New York
$675K – – –
ProShare Advisors
69
ProShare Advisors
Maryland
$670K +$47.3K +1,500 +8%
RE
70
RBC Europe
United Kingdom
$658K +$647K +20,500 New
BPM
71
Bowling Portfolio Management
Ohio
$640K +$629K +19,947 New
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$567K – – –
PP
73
PDT Partners
New York
$538K -$82K -2,600 -13%
DekaBank Deutsche Girozentrale
74
DekaBank Deutsche Girozentrale
Germany
$525K – – –
CCMH
75
Cornerstone Capital Management Holdings
New York
$524K +$94.6K +3,000 +22%
1 2
3
4 5

GHDX Hedge Fund Activity: Q3 2017 in Review

134 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q3 2017, worth a combined $1.01B — up 0.08% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new GHDX positions and 7 closed out — a net gain of 12 holders — while 58 added to existing stakes and 29 trimmed.

The largest buyer was Millennium Management, adding an estimated $13.3M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $8.86M.

  • 134 institutional investors held Genomic Health, Inc. (GHDX) as of Q3 2017, up from 124 in Q2 2017.
  • Funds reported $1.01B of Genomic Health, Inc. stock for Q3 2017, up 0.08% quarter-over-quarter.
  • 19 funds opened new Genomic Health, Inc. positions in Q3 2017 and 7 closed out, a net change of +12 holders.
  • The largest Genomic Health, Inc. buyer in Q3 2017 was Millennium Management, an estimated $13.3M added.
  • The largest Genomic Health, Inc. seller in Q3 2017 was Columbia Wanger Asset Management, an estimated $8.86M sold.

Based on aggregated 13F filings for Q3 2017.